AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30148752 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete Mesocolic Excision (CME)
Number of subjects: 330
Study 30148752 — intervention group
Group type: COMPARATOR
Intervention: Noncomplete Mesocolic Excision (NCME)
Number of subjects: 330
Study 31326304 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral l-arginine plus tadalafil
Number of subjects: 108
Study 31326304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 31326304 — intervention group
Group type: COMPARATOR
Intervention: Single drugs (either l-arginine or tadalafil)
Number of subjects: 108
Study 28012273 — intervention group
Group type: EXPERIMENTAL
Intervention: During menstruation (days 1-7)
Number of subjects: 112
Study 28012273 — intervention group
Group type: COMPARATOR
Intervention: Outside menstruation (any day after menstruation without vaginal blood loss)
Number of subjects: 112
Study 26051738 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaliplatin combined with flurouracil
Number of subjects: 60
Study 26051738 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX4 (control)
Number of subjects: 60
Study 23790420 — intervention group
Group type: EXPERIMENTAL
Intervention: Night extension orthosis plus hand therapy
Number of subjects: 56
Study 23790420 — intervention group
Group type: COMPARATOR
Intervention: Hand therapy alone
Number of subjects: 56
Study 23790420 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sample
Number of subjects: 56
Study 21871480 — intervention group
Group type: EXPERIMENTAL
Intervention: General SMS-text reminder
Number of subjects: 385
Study 21871480 — intervention group
Group type: COMPARATOR
Intervention: Informative SMS-text reminder
Number of subjects: 385
Study 19339412 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin target of 13.5 to 14.5 g/dl
Number of subjects: 596
Study 19339412 — intervention group
Group type: COMPARATOR
Intervention: Hemoglobin target of 9.5 to 11.5 g/dl
Number of subjects: 596
Study 16479247 — intervention group
Group type: EXPERIMENTAL
Intervention: Striatal dopamine transporter density in ADHD patients
Number of subjects: 20
Study 16479247 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 20
Study 14683745 — intervention group
Group type: EXPERIMENTAL
Intervention: Stents
Number of subjects: 8004
Study 11137633 — intervention group
Group type: COMPARATOR
Intervention: No protective layer (Group 1)
Number of subjects: 319
Study 11137633 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide base (Group 2)
Number of subjects: 319
Study 11137633 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer cement (Group 3)
Number of subjects: 319
Study 11137633 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide base + glass ionomer cement (Group 4)
Number of subjects: 319
Study 11137633 — intervention group
Group type: EXPERIMENTAL
Intervention: Shallow and medium depth cavities
Number of subjects: 319
Study 11137633 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer generation dentine‐bonding agents
Number of subjects: 319
Study 9542612 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk challenge
Number of subjects: 20
Study 7869013 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (4 to 8 mg) monotherapy
Number of subjects: 95
Study 7869013 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (4 to 8 mg) in combination with hydrochlorothiazide (50 mg/day)
Number of subjects: 95
Study 7869013 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 2832030 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH, Enoxaparine) 60 mg daily
Number of subjects: 892
Study 2832030 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH, Enoxaparine) 40 mg daily
Number of subjects: 892
Study 2832030 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH, Enoxaparine) 20 mg daily
Number of subjects: 892
Study 2832030 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UH) 5000 units daily
Number of subjects: 892
Study 31980285 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin (10 mg BID)
Number of subjects: 12
Study 31980285 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg BID)
Number of subjects: 12
Study 29220627 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 28
Study 29220627 — intervention group
Group type: COMPARATOR
Intervention: Active Control Group
Number of subjects: 28
Study 28160750 — intervention group
Group type: EXPERIMENTAL
Intervention: RPMS+training
Number of subjects: 21
Study 28160750 — intervention group
Group type: COMPARATOR
Intervention: Sham+training
Number of subjects: 21
Study 26112014 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management programme
Number of subjects: 148
Study 24306011 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated Resolution Therapy (ART)
Number of subjects: 57
Study 24306011 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (AC)
Number of subjects: 57
Study 20515235 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized single-case intervention designs
Number of subjects: 0
Study 20515235 — intervention group
Group type: COMPARATOR
Intervention: Traditional single-case designs
Number of subjects: 0
Study 17976888 — intervention group
Group type: EXPERIMENTAL
Intervention: 2h training
Number of subjects: 1095
Study 17976888 — intervention group
Group type: EXPERIMENTAL
Intervention: 4h training
Number of subjects: 1095
Study 17976888 — intervention group
Group type: EXPERIMENTAL
Intervention: 7h training
Number of subjects: 1095
Study 17976888 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month retest
Number of subjects: 1095
Study 17976888 — intervention group
Group type: COMPARATOR
Intervention: No 6-month retest
Number of subjects: 1095
Study 16386812 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 117
Study 16386812 — intervention group
Group type: COMPARATOR
Intervention: No alcohol
Number of subjects: 117
Study 14703598 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CRP > 10 pg/mL plus IL‐6 > 18 pg/mL at 0-hour
Number of subjects: 105
Study 14703598 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP at 24-hours
Number of subjects: 105
Study 14703598 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐6 at 0-hour
Number of subjects: 105
Study 14703598 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐8 at 24-hours
Number of subjects: 105
Study 10716520 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers (n = 33)
Number of subjects: 65
Study 10716520 — intervention group
Group type: COMPARATOR
Intervention: No beta-blockers (n = 32)
Number of subjects: 65
Study 8852689 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral stimuli
Number of subjects: 0
Study 8852689 — intervention group
Group type: COMPARATOR
Intervention: Unilateral stimuli
Number of subjects: 0
Study 8852689 — intervention group
Group type: EXPERIMENTAL
Intervention: Extinguished stimulus on the field contralateral to the lesion
Number of subjects: 0
Study 1641252 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (expulsion of Trichuris trichiura)
Number of subjects: 159
Study 1641252 — intervention group
Group type: COMPARATOR
Intervention: Control (uninfected children)
Number of subjects: 159
Study 6829944 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane at 3.5% concentration
Number of subjects: 60
Study 6829944 — intervention group
Group type: COMPARATOR
Intervention: Atropine 0.02 mg/kg intramuscularly before induction
Number of subjects: 60
Study 31860965 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O titration (30% to ideal sedation concentration)
Number of subjects: 70
Study 31860965 — intervention group
Group type: COMPARATOR
Intervention: 50% N2O (control)
Number of subjects: 70
Study 31860965 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O titration
Number of subjects: 70
Study 29726999 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 28
Study 29726999 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone (MPA)
Number of subjects: 28
Study 29726999 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 28
Study 27418682 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (11.91 mmol nitrate)
Number of subjects: 31
Study 27418682 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (placebo, 0.01 mmol nitrate)
Number of subjects: 31
Study 24595714 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention delivered by community health workers
Number of subjects: 0
Study 24595714 — intervention group
Group type: COMPARATOR
Intervention: Control group (received educational pamphlets)
Number of subjects: 0
Study 22951193 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of methylprednisolonacetate
Number of subjects: 160
Study 22951193 — intervention group
Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 160
Study 20233176 — intervention group
Group type: EXPERIMENTAL
Intervention: Homoeopathic granules
Number of subjects: 92
Study 20233176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 18569053 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly structured approach
Number of subjects: 52
Study 18569053 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided exercise approach
Number of subjects: 52
Study 18569053 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit training approach
Number of subjects: 52
Study 16421163 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin, 50 units/kg once per week
Number of subjects: 48
Study 16421163 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin (in vitro treatment of PBMs)
Number of subjects: 48
Study 16421163 — intervention group
Group type: COMPARATOR
Intervention: Control group (normolipidemic healthy volunteers)
Number of subjects: 48
Study 16421163 — intervention group
Group type: COMPARATOR
Intervention: Group II (untreated patients)
Number of subjects: 48
Study 12671377 — intervention group
Group type: EXPERIMENTAL
Intervention: Vivostat patient-derived fibrin sealant
Number of subjects: 0
Study 12671377 — intervention group
Group type: COMPARATOR
Intervention: Thrombin solution (control)
Number of subjects: 0
Study 10561316 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone and hydrocortisone (M+H)
Number of subjects: 242
Study 10561316 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone alone
Number of subjects: 242
Study 8916861 — intervention group
Group type: EXPERIMENTAL
Intervention: Preincisional infiltration of the tonsils with bupivacaine hydrochloride
Number of subjects: 129
Study 1882909 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (1-g tablet twice a day for 4 months)
Number of subjects: 254
Study 1882909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 6133059 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 mmol sodium alpha‐ketoisocaproate (KIC)
Number of subjects: 21
Study 6133059 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 mmol leucine
Number of subjects: 21
Study 6133059 — intervention group
Group type: COMPARATOR
Intervention: 10 g glucose plus 70 mmol NaHCO3
Number of subjects: 21
Study 29143290 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 32
Study 29143290 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 32
Study 28125980 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined music and touch intervention (CMT)
Number of subjects: 62
Study 28125980 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CMT)
Number of subjects: 62
Study 25449185 — intervention group
Group type: EXPERIMENTAL
Intervention: YOCAS©® intervention (4-week yoga intervention)
Number of subjects: 97
Study 25449185 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 97
Study 23223405 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 3942
Study 23223405 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 3942
Study 21986165 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid-based cytology (LBC)
Number of subjects: 58
Study 21986165 — intervention group
Group type: COMPARATOR
Intervention: Conventional smear method (SMEAR)
Number of subjects: 58
Study 17970794 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive episiotomy policy
Number of subjects: 774
Study 17970794 — intervention group
Group type: COMPARATOR
Intervention: Routine episiotomy policy
Number of subjects: 774
Study 16449709 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepine tapering-off programme without psychotherapy
Number of subjects: 102
Study 16449709 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 102
Study 12882612 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual ratings by 11 raters
Number of subjects: 145
Study 12882612 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensus ratings by groups of 2 or 3 raters
Number of subjects: 145
Study 12882612 — intervention group
Group type: EXPERIMENTAL
Intervention: Total score by individual raters
Number of subjects: 145
Study 12882612 — intervention group
Group type: EXPERIMENTAL
Intervention: Total score by consensus ratings
Number of subjects: 145
Study 11710399 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromium picolinate (CrPic) supplementation (500 ug once per day)
Number of subjects: 15
Study 11710399 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 15
Study 11710399 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromium picolinate (CrPic) supplementation
Number of subjects: 15
Study 9419047 — intervention group
Group type: EXPERIMENTAL
Intervention: ALSFRS (Amyotrophic Lateral Sclerosis Functional Rating Scale)
Number of subjects: 0
Study 9419047 — intervention group
Group type: COMPARATOR
Intervention: Placebo (from ALS CNTF Treatment Study)
Number of subjects: 0
Study 8272248 — intervention group
Group type: EXPERIMENTAL
Intervention: Duo-Flux Artificial Kidney
Number of subjects: 0
Study 8272248 — intervention group
Group type: EXPERIMENTAL
Intervention: F 60
Number of subjects: 0
Study 8272248 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtral
Number of subjects: 0
Study 8272248 — intervention group
Group type: COMPARATOR
Intervention: cuprammonium cellulose plate
Number of subjects: 0
Study 8272248 — intervention group
Group type: COMPARATOR
Intervention: CD 4000
Number of subjects: 0
Study 3525270 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose meal (50 g) with Acarbose 100 mg
Number of subjects: 9
Study 3525270 — intervention group
Group type: COMPARATOR
Intervention: Sucrose meal (50 g) without Acarbose
Number of subjects: 9
Study 3525270 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose meal (75 g) with Acarbose 100 mg
Number of subjects: 9
Study 3525270 — intervention group
Group type: COMPARATOR
Intervention: Sucrose meal (75 g) without Acarbose
Number of subjects: 9
Study 3525270 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose meal (100 g) with Acarbose 100 mg
Number of subjects: 9
Study 3525270 — intervention group
Group type: COMPARATOR
Intervention: Sucrose meal (100 g) without Acarbose
Number of subjects: 9
Study 3525270 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (0 mg, 50 mg, 100 mg, 200 mg) with fixed sucrose load (75 g)
Number of subjects: 9
Study 31749273 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive episiotomy
Number of subjects: 3006
Study 31749273 — intervention group
Group type: COMPARATOR
Intervention: Routine episiotomy
Number of subjects: 3006
Study 29406289 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding self-efficacy intervention (n = 60)
Number of subjects: 120
Study 29406289 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 60)
Number of subjects: 120
Study 26921093 — intervention group
Group type: EXPERIMENTAL
Intervention: BF-200 ALA
Number of subjects: 94
Study 26921093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 24613816 — intervention group
Group type: EXPERIMENTAL
Intervention: HFX (hyperfractionation), 81.6 Gy/68 twice‐daily fractions/7 weeks
Number of subjects: 1076
Study 24613816 — intervention group
Group type: EXPERIMENTAL
Intervention: AFX-C (accelerated fractionation continuous), 72 Gy/42 fractions/6 weeks
Number of subjects: 1076
Study 24613816 — intervention group
Group type: COMPARATOR
Intervention: SFX (standard fractionation), 70 Gy/35 daily fractions/7 weeks
Number of subjects: 1076
Study 24613816 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-week treatments
Number of subjects: 1076
Study 24151792 — intervention group
Group type: EXPERIMENTAL
Intervention: Training preschool teachers using a manual covering health education, health promotion, incorporation of oral‐health‐friendly activities into the preschool curriculum, and hands‐on experience of oral examination.
Number of subjects: 72
Study 21972404 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C19 loss-of-function allele carrier
Number of subjects: 371
Study 21972404 — intervention group
Group type: COMPARATOR
Intervention: PON1 QQ192
Number of subjects: 371
Study 21972404 — intervention group
Group type: COMPARATOR
Intervention: PON1 LL55
Number of subjects: 371
Study 18435367 — intervention group
Group type: EXPERIMENTAL
Intervention: Finishing with a 30 microm finishing diamond by human operators and mechanical device
Number of subjects: 120
Study 18435367 — intervention group
Group type: EXPERIMENTAL
Intervention: Polishing with Astropol polishing cups by human operators and mechanical device
Number of subjects: 120
Study 18435367 — intervention group
Group type: EXPERIMENTAL
Intervention: Finishing and polishing at baseline and after 48 hours
Number of subjects: 120
Study 16970691 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm neutral tumescent anesthesia (40 degrees C)
Number of subjects: 36
Study 16970691 — intervention group
Group type: COMPARATOR
Intervention: Room-temperature neutral tumescent anesthesia (22 degrees C)
Number of subjects: 36
Study 16970691 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm nonneutral tumescent anesthesia (pH 4.78)
Number of subjects: 36
Study 16970691 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm neutral tumescent anesthesia (pH 7.35)
Number of subjects: 36
Study 16970691 — intervention group
Group type: COMPARATOR
Intervention: Room-temperature nonneutral tumescent anesthesia
Number of subjects: 36
Study 14597032 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP lowering by 30%
Number of subjects: 144
Study 14597032 — intervention group
Group type: COMPARATOR
Intervention: No IOP-lowering treatment
Number of subjects: 144
Study 11022197 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with type 1 diabetes (IDDM)
Number of subjects: 134
Study 11022197 — intervention group
Group type: COMPARATOR
Intervention: Reference population
Number of subjects: 134
Study 11022197 — intervention group
Group type: EXPERIMENTAL
Intervention: Male patients with type 1 diabetes (IDDM)
Number of subjects: 134
Study 11022197 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients with type 1 diabetes (IDDM)
Number of subjects: 134
Study 8810585 — intervention group
Group type: EXPERIMENTAL
Intervention: Do not intervene instructions
Number of subjects: 0
Study 8810585 — intervention group
Group type: COMPARATOR
Intervention: Try to stay with the pattern instructions
Number of subjects: 0
Study 1442914 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonated lidocaine (10 cm3 of 2%)
Number of subjects: 100
Study 1442914 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep injection technique with plain lidocaine
Number of subjects: 100
Study 1442914 — intervention group
Group type: COMPARATOR
Intervention: Plain lidocaine (control group from phase 1)
Number of subjects: 100
Study 3956889 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotelemetry capsule measurements
Number of subjects: 4
Study 3956889 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 3956889 — intervention group
Group type: EXPERIMENTAL
Intervention: Antisecretory agent
Number of subjects: 4
Study 30244873 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted PCV15
Number of subjects: 0
Study 30244873 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonadjuvanted PCV15
Number of subjects: 0
Study 30244873 — intervention group
Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 0
Study 30244873 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV15 (both formulations)
Number of subjects: 0
Study 27303064 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain-activating rehabilitation (BAR) conducted for 1 hour, 3 times a week
Number of subjects: 48
Study 27303064 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 48
Study 25008086 — intervention group
Group type: EXPERIMENTAL
Intervention: Static magnetic field (SMF) exposure with peak-to-peak magnetic induction of 3 mT and 30 mT m(‐1) gradient for 30 minutes
Number of subjects: 16
Study 22739624 — intervention group
Group type: EXPERIMENTAL
Intervention: Black soy peptide supplementation (test group, n = 35)
Number of subjects: 80
Study 22739624 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group, n = 29)
Number of subjects: 80
Study 20721420 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing Consultation Protocol
Number of subjects: 146
Study 20721420 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 146
Study 18393051 — intervention group
Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory total score greater than 20
Number of subjects: 526
Study 18393051 — intervention group
Group type: EXPERIMENTAL
Intervention: One or more prior suicide attempts
Number of subjects: 526
Study 16542488 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous pulmonary surfactant
Number of subjects: 5
Study 14514406 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic tracheostomy (PT)
Number of subjects: 93
Study 14514406 — intervention group
Group type: COMPARATOR
Intervention: Emergent tracheostomy (ET)
Number of subjects: 93
Study 11071086 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapy (duration: 72-96 hours)
Number of subjects: 20
Study 11071086 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture positive MEF
Number of subjects: 20
Study 11071086 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture negative MEF
Number of subjects: 20